Business / Finance

RSS

KAI enters KAI-4169 development and commercialization agreement with Ono

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.

15 Sep 2011

ViroPharma expands securities repurchase program

ViroPharma Incorporated today announced that the company's Board of Directors has authorized the use of up to an additional $200 million to repurchase shares of its common stock and/or its 2% Senior Convertible Notes due 2017.

15 Sep 2011

China Botanic third-quarter net sales increase 33.6% to $12.4 million

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines in China, today announced financial results for the three months ended July 31, 2011.

15 Sep 2011

Tyco reaches agreement to acquire Visonic

Tyco International Ltd. announced today that it has reached an agreement to acquire Visonic Ltd., a global developer and manufacturer of electronic security systems and components, for approximately $100 million in cash. The acquisition will strengthen the wireless product and technology portfolio and market presence of the Tyco Security Products business in the intrusion security market.

15 Sep 2011

Miracor closes first round of Series B financing

Miracor Medical Systems GmbH, a private Austrian medical device company, announced today that the company has secured €7M/$10M in the first closing of the Series B financing round.

14 Sep 2011

AM-Pharma announces €29.2m series D round of financing

AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.

13 Sep 2011

FDA announces organizational changes within CDER's Office of Oncology Drug Products

Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies.

13 Sep 2011

Modern Plastics named distributor for new EVONIK VESTAKEEP 5000 PEEK extruded stock shapes

Modern Plastics, one of the largest distributors of high-performance and engineering-grade stock shapes and medical-grade plastics, is a distributor for new EVONIK VESTAKEEP® 5000 PEEK extruded stock shapes.

12 Sep 2011

CHRISTUS Health renews Spend and Clinical Resource Management relationship with MedAssets

MedAssets today announced that long-time customer CHRISTUS Health, a Catholic, faith-based, not-for-profit health system headquartered in Irving, Texas, recently elected to renew its Spend and Clinical Resource Management relationship with the company.

12 Sep 2011

Frontage, Spaulding Clinical enter strategic partnership

Frontage Laboratories, Inc., a global full-service Clinical Research Organization with facilities in the US and China, and Spaulding Clinical Research, LLC, a US-based, leading-edge Clinical Pharmacology Unit, ECG Core Lab, and Medical Device Manufacturer have entered into a strategic partnership agreement.

12 Sep 2011

American Scientific Resources receives first purchase order from ANB Canada

American Scientific Resources, Inc. today announced that it received its first purchase order from Associated National Brokerage, Inc., a major distributor of health and beauty products to chain drug stores throughout Canada.

12 Sep 2011

CEO Roundtable on Cancer bestows Gold Standard accreditation to Memorial Sloan-Kettering

Memorial Sloan-Kettering Cancer Center has received CEO Cancer Gold Standard accreditation, recognizing the center's commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members, as well as the patients whom they serve.

12 Sep 2011

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha Therapeutics announced today that it has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes.

12 Sep 2011

LabCorp extends previously announced cash tender offer for Orchid Cellmark shares

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 5:00 p.m., New York City time, on October 7, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc..

12 Sep 2011

Bruker to acquire Center for Tribology

Bruker Corporation today announced the signing of a purchase agreement to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.

12 Sep 2011

Valeritas completes Series C round of financing

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million.

12 Sep 2011

Tenet Healthcare refines 2011 Outlook for Adjusted EBITDA

In advance of scheduled investor meetings and the Company's participation at an industry conference, Tenet Healthcare Corporation today refined its 2011 Outlook for Adjusted EBITDA.

12 Sep 2011

Rich countries watering down NCD commitments to appease multinational companies

Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.

9 Sep 2011

Quest Diagnostics placed on Dow Jones Sustainability Indexes

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones® Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America).

From Quest Diagnostics 9 Sep 2011

Patheon third quarter revenues increase 5.8% to $172.7 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today: Details of Patheon's new corporate strategy, including an initial heavy focus on strengthening the company's core operations.

9 Sep 2011